These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 16445943)

  • 21. Cerebrotendinous xanthomatosis (CTX): a treatable lipid storage disease.
    Keren Z; Falik-Zaccai TC
    Pediatr Endocrinol Rev; 2009 Sep; 7(1):6-11. PubMed ID: 19696711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Usefulness of cholestanol levels in the diagnosis and follow-up of patients with cerebrotendinous xanthomatosis].
    Pilo de la Fuente B; Sobrido MJ; Girós M; Pozo L; Lustres M; Barrero F; Macarrón J; Díaz M; Jiménez-Escrig A
    Neurologia; 2011 Sep; 26(7):397-404. PubMed ID: 21345536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cerebrotendinous xanthomatosis].
    Inoue K; Kubota S; Seyama Y
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():348-52. PubMed ID: 11347094
    [No Abstract]   [Full Text] [Related]  

  • 24. A case of Cerebrotendinous Xanthomatosis with spinal cord involvement and without tendon xanthomas: identification of a new mutation of the CYP27A1 gene.
    Gelzo M; Di Taranto MD; Bisecco A; D'Amico A; Capuano R; Giacobbe C; Caputo M; Cirillo M; Tedeschi G; Fortunato G; Corso G
    Acta Neurol Belg; 2021 Apr; 121(2):561-566. PubMed ID: 31875301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cerebrotendinous xanthomatosis. Report of one case].
    Contreras JP; Guajardo G; Martínez A; López I; Cea G
    Rev Med Chil; 2019 May; 147(5):658-662. PubMed ID: 31859899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The wide spectrum of cerebrotendinous xanthomatosis: Case report of a rare but treatable disease.
    Rosafio F; Cavallieri F; Guaraldi P; Taroni F; Nichelli PF; Mandrioli J
    Clin Neurol Neurosurg; 2016 Apr; 143():1-3. PubMed ID: 26874936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebrotendinous Xanthomatosis: Molecular Pathogenesis, Clinical Spectrum, Diagnosis, and Disease-Modifying Treatments.
    Koyama S; Sekijima Y; Ogura M; Hori M; Matsuki K; Miida T; Harada-Shiba M
    J Atheroscler Thromb; 2021 Sep; 28(9):905-925. PubMed ID: 33967188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and radiological findings of a cerebrotendinous xanthomatosis patient with a novel p.A335V mutation in the CYP27A1 gene.
    Yoshinaga T; Sekijima Y; Koyama S; Maruyama K; Yoshida T; Kato T; Ikeda S
    Intern Med; 2014; 53(23):2725-9. PubMed ID: 25447658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of cholesterol metabolism in cerebrotendinous xanthomatosis.
    Mignarri A; Magni A; Del Puppo M; Gallus GN; Björkhem I; Federico A; Dotti MT
    J Inherit Metab Dis; 2016 Jan; 39(1):75-83. PubMed ID: 26153518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three siblings with Cerebrotendinous Xanthomatosis: a novel mutation in the CYP27A1 gene.
    Suh S; Kim HK; Park HD; Ki CS; Kim MY; Jin SM; Kim SW; Hur KY; Kim KW; Kim JH
    Eur J Med Genet; 2012 Jan; 55(1):71-4. PubMed ID: 21958693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of cerebrotendinous xanthomatosis with brain and spinal involvement without tendon xanthomas: Identification of a novel mutation of the CYP27A1 gene.
    Stenos C; Kalafatakis K; Constantoulakis P; Zekiou K; Margoni A; Kardara P; Terentiou A; Stouraitis G; Nikolaou G
    J Clin Lipidol; 2022; 16(3):281-285. PubMed ID: 35428606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pathophysiology of cerebrotendinous xanthomatosis].
    Koyama S; Kato T
    Rinsho Shinkeigaku; 2016 Dec; 56(12):821-826. PubMed ID: 27840382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and molecular diagnosis of cerebrotendinous xanthomatosis with a review of the mutations in the CYP27A1 gene.
    Gallus GN; Dotti MT; Federico A
    Neurol Sci; 2006 Jun; 27(2):143-9. PubMed ID: 16816916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two novel mutations in the sterol 27-hydroxylase gene causing cerebrotendinous xanthomatosis.
    Lamon-Fava S; Schaefer EJ; Garuti R; Salen G; Calandra S
    Clin Genet; 2002 Mar; 61(3):185-91. PubMed ID: 12000359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isotopomer spectral analysis of intermediates of cholesterol synthesis in patients with cerebrotendinous xanthomatosis.
    Clarenbach JJ; Lindenthal B; Dotti MT; Federico A; Kelleher JK; von Bergmann K
    Metabolism; 2005 Mar; 54(3):335-44. PubMed ID: 15736111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of accumulation of cholesterol and cholestanol in tendons and the role of sterol 27-hydroxylase (CYP27A1).
    von Bahr S; Movin T; Papadogiannakis N; Pikuleva I; Rönnow P; Diczfalusy U; Björkhem I
    Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1129-35. PubMed ID: 12117727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical, biochemical, and molecular insights into Cerebrotendinous Xanthomatosis: A nationwide study of 100 Turkish individuals.
    Zubarioglu T; Kıykım E; Köse E; Eminoğlu FT; Teke Kısa P; Balcı MC; Özer I; İnci A; Çilesiz K; Canda E; Yazıcı H; Öztürk-Hişmi B; Bulut FD; Dorum S; Akgun A; Yalçın-Çakmaklı G; Kılıç-Yıldırım G; Soyuçen E; Akçalı A; Güneş D; Durmuş A; Gündüz A; Kasapkara ÇS; Göksoy E; Akar HT; Ersoy M; Erdöl Ş; Yıldız Y; Hanağası HA; Arslan N; Aktuğlu-Zeybek Ç
    Mol Genet Metab; 2024 Jun; 142(2):108493. PubMed ID: 38772327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and biochemical features, molecular diagnosis and long-term management of a case of cerebrotendinous xanthomatosis.
    Burnett JR; Moses EA; Croft KD; Brown AJ; Grainger K; Vasikaran SD; Leitersdorf E; Watts GF
    Clin Chim Acta; 2001 Apr; 306(1-2):63-9. PubMed ID: 11282095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apparent underdiagnosis of Cerebrotendinous Xanthomatosis revealed by analysis of ~60,000 human exomes.
    Appadurai V; DeBarber A; Chiang PW; Patel SB; Steiner RD; Tyler C; Bonnen PE
    Mol Genet Metab; 2015 Dec; 116(4):298-304. PubMed ID: 26643207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Normalisation of serum cholestanol concentration in a patient with cerebrotendinous xanthomatosis by combined treatment with chenodeoxycholic acid, simvastatin and LDL apheresis.
    Dotti MT; Lütjohann D; von Bergmann K; Federico A
    Neurol Sci; 2004 Oct; 25(4):185-91. PubMed ID: 15549503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.